Literature DB >> 9506753

Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density.

L Gennari1, L Becherini, L Masi, R Mansani, S Gonnelli, C Cepollaro, S Martini, A Montagnani, G Lentini, A M Becorpi, M L Brandi.   

Abstract

Bone mass and bone turnover are under genetic control. Restriction fragment length polymorphisms (RFLPs) at the vitamin D receptor (VDR) gene locus have been recently correlated to bone mineral density (BMD) and rate of bone loss. However, agreement on this relationship is not universal. The existence of ethnical and environmental differences between populations, a health-based selection bias in several previous studies, and the involvement of other genes could explain these discordant findings. In this study, we examined the relationship of VDR and estrogen receptor (ER) gene RFLPs with lumbar spine and upper femur BMD in 426 Italian postmenopausal women, 57.7 +/- 0.4 yr old (144 normal, 106 osteopenic, and 176 osteoporotic). VDR gene RFLPs for ApaI, Bsm I, and TaqI restriction endonucleases and ER RFLPs for PvuII and XbaI restriction endonucleases were assessed by Southern blotting analysis and were indicated, respectively, as A-a, B-b, T-t, P-p, and X-x (uppercase letters signifying the absence and lowercase letters the presence of the restriction site). After correcting for potential confounding factors (age, height, weight, age since menopause, osteophytosis, and facet joint osteoarthritis), a statistically significant VDR genotype effect on lumbar BMD (P = 0.01, analysis of covariance), but not on femoral BMD, was detected, with subjects in AABBtt genotype showing a 13% lower BMD than those with aabbTT genotype (P < 0.05, Tukey's test). Moreover, a statistically significant prevalence of AABBtt genotype in osteoporotics, and of AabbTT and aabbTT genotypes in nonosteoporotics, were detected. Conversely, there was no significant relationship of ER genotype to either lumbar or femoral BMD, even though a trend for higher BMD values in women with the ER PP genotype (with respect to those with ER pp genotype) was detected. When mean lumbar BMD was calculated for women grouped by ER and VDR genotype, we observed a significant difference between those within the 2 opposite associations AABBtt-PPXX and aabbTT-ppxx (0.71 +/- 0.05 vs. 0.97 +/- 0.03 g/cm2, P < 0.05 Tukey's test). These results are consistent with a segregation of the VDR AABBtt genotype with a higher risk of developing osteoporosis, in the Italian female population. The introduction of another variable, the ER genotype, in the analysis of VDR genetic determination of BMD, may represent a useful model in the identification of patients at risk of developing a multigenic disorder like osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506753     DOI: 10.1210/jcem.83.3.4649

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

Review 1.  Genetics of osteoporosis.

Authors:  S H Ralston
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  Association between ER-α polymorphisms and bone mineral density in patients with Turner syndrome subjected to estroprogestagen treatment--a pilot study.

Authors:  Elżbieta Sowińska-Przepiera; Elżbieta Andrysiak-Mamos; Kornel Chełstowski; Grażyna Adler; Zbigniew Friebe; Anhelli Syrenicz
Journal:  J Bone Miner Metab       Date:  2011-01-27       Impact factor: 2.626

3.  Association between bone mineral density and polymorphisms of the VDR, ERalpha, COL1A1 and CTR genes in Spanish postmenopausal women.

Authors:  E Bandrés; I Pombo; M González-Huarriz; A Rebollo; G López; J García-Foncillas
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

4.  Bone health, genetics, and personalised nutrition.

Authors:  Kevin D Cashman; Kelly Seamans
Journal:  Genes Nutr       Date:  2007-10       Impact factor: 5.523

5.  Association study of estrogen receptor alpha gene polymorphisms with bone mass assessed by quantitative ultrasound in young adults.

Authors:  María Correa-Rodriguez; Jacqueline Schmidt-RioValle; Blanca Rueda-Medina
Journal:  Rheumatol Int       Date:  2017-05-22       Impact factor: 2.631

6.  BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial.

Authors:  Stefano Palomba; Francesco Orio; Tiziana Russo; Angela Falbo; Achille Tolino; Francesco Manguso; Vincenzo Nunziata; Pasquale Mastrantonio; Gaetano Lombardi; Fulvio Zullo
Journal:  Osteoporos Int       Date:  2005-03-01       Impact factor: 4.507

7.  Genetic and environmental factors in human osteoporosis.

Authors:  Halil Özbaş; Serap Tutgun Onrat; Kazım Özdamar
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

8.  Frequency of fokI and taqI polymorphism of vitamin D receptor gene in Indian population and its association with 25-hydroxyvitamin D levels.

Authors:  Aparna A Bhanushali; Namrata Lajpal; Smita S Kulkarni; Sandeep S Chavan; Sarita S Bagadi; Bibhu R Das
Journal:  Indian J Hum Genet       Date:  2009-09

9.  Interaction effects between estrogen receptor alpha gene, vitamin D receptor gene, age, and sex on bone mineral density in Chinese.

Authors:  Jirong Long; Pengyuan Liu; Yuanyuan Zhang; Hui Shen; Yongjun Liu; Volodymyr Dvornyk; Hong-Wen Deng
Journal:  J Hum Genet       Date:  2003-09-19       Impact factor: 3.172

10.  Haplotype analysis of VDR gene polymorphisms: a meta-analysis.

Authors:  Ammarin Thakkinstian; Catherine D'Este; John Attia
Journal:  Osteoporos Int       Date:  2004-04-01       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.